Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF CASH FLOWS

v3.21.2
CONDENSED STATEMENT OF CASH FLOWS
 9 Months Ended
Sep. 30, 2021
USD ($)
Cash Flows from Operating Activities:  
Net income $ (2,039,496)
Adjustment to reconcile net income to net cash used in operating activities:  
Income from investments held in Trust Account (13,239)
Change in fair value of derivative warrant liabilities (4,235,500)
Offering costs - derivative warrant liabilities 590,295
Changes in operating assets and liabilities:  
Prepaid expenses (259,778)
Accounts payable 406,144
Accrued expenses 391,205
Due to related party 50,813
Net cash used in operating activities (1,030,564)
Cash Flows from Investing Activities:  
Cash deposited in Trust Account (287,500,000)
Net cash used in investing activities (287,500,000)
Cash Flows from Financing Activities:  
Payment of note payable to related party (78,625)
Proceeds received from initial public offering, gross 287,500,000
Proceeds received from private placement 8,000,000
Offering costs paid (6,155,498)
Net cash provided by financing activities 289,265,877
Net change in cash 735,313
Cash - beginning of the period 0
Cash - end of the period 735,313
Supplemental disclosure of noncash financing activities:  
Deferred offering costs included in accrued expenses 15,000
Deferred offering costs included in note payable 35,000
Deferred underwriting commissions $ 10,062,500